Non-Communicable Chronic Diseases Among Residents of a Remote Settlement in the Transbaikal Region of the Russian Federation

Article Sidebar

PDF
Published: May 13, 2019
DOI: https://doi.org/10.5195/cajgh.2019.338
Keywords:
Chronic Noncommunicable Diseases Screening Programs Vascular Stiffness Circulatory System Diseases Mortality

Main Article Content

Oleg Gaisenok
Research Center for Medical Forecasting and Analysis, Moscow, Russia; United Hospital with Outpatient Department, Moscow, Russia

Abstract

Introduction: Over a quarter of the population of the Russian Federation resides in rural communities. However, the data on chronic disease rates in these communities are limited, which makes screening for chronic diseases extremely important. The aim of this study was to measure the prevalence of chronic noncommunicable diseases among residents of a remote settlement in the Transbaikal region, Russian Federation.

Methods: A sample of residents from the Transbaikal region settlement was screened in August 2017. The screening included a survey to determine the frequency of self-reported chronic diseases as well as sociodemographic and behavioral risk factors. Additionally, vascular stiffness was measured by volumetric sphygmography using the VaSera-1500 device. Descriptive statistics have been used for data analysis.

Results: 126 residents were screened for this study. The prevalence of chronic non-communicable diseases and their risk factors were: hypertension (56.3%), gastrointestinal diseases (33.3%), chronic obstructive pulmonary disease (13.5%), smoking (35.7%), obesity (19.1%), and diabetes mellitus (6.3%). Pathological vascular changes typical of atherosclerosis were found by volumetric sphygmography in 17.5% of cases, with 5.5% of those cases corresponding to significant forms of severe peripheral atherosclerosis (ABI<0.9). An analysis of mortality causes for this settlement for 2016-2017 found that cardiovascular diseases accounted for over 50% of the total number of deaths.

Conclusion: This study showed a high prevalence of detectable chronic non-communicable diseases and their associated risk factors. Cardiovascular diseases were the main cause of mortality. Active prevention programs and screenings are required to reduce the burden of chronic diseases in this region.

Article Details

How to Cite
Gaisenok, O. (2019). Non-Communicable Chronic Diseases Among Residents of a Remote Settlement in the Transbaikal Region of the Russian Federation. Central Asian Journal of Global Health, 8(1). https://doi.org/10.5195/cajgh.2019.338
Issue
Vol. 8 No. 1 (2019)
Section
Research

Authors who publish with this journal agree to the following terms:

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
    with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
  4. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
  5. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
  6. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
  7. The Author represents and warrants that:
    1. the Work is the Author’s original work;
    2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
    3. the Work is not pending review or under consideration by another publisher;
    4. the Work has not previously been published;
    5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
    6. the Work contains no libel, invasion of privacy, or other unlawful matter.
  8. The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Revised 7/16/2018. Revision Description: Removed outdated link. 

References

Heart Disease and Stroke Statistics-2017 Update: A Report from the American Heart Association. Circulation. 2017 Mar 7;135(10): e146-e603.

Estimate of the number of resident population on January 1, 2018 and an average for 2017. www.gks.ru/free_doc/new_site/population/demo/PrPopul2018.xlsx. Accessed on 13 May 2019.

Shalnova S.A., Konradi A.O., Karpov Yu.A., Kontsevaya A.V., Deev A.D., Kapustina A.V., Khudyakov M.B., Shlyakhto E.V., Boytsov S.A. Cardiovascular mortality in 12 Russian Federation regions – participants of the “Cardiovascular Disease Epidemiology in Russian Regions” study. Russ J Cardiol 2012, 5 (97): 6-11. [In Russ.]

Shalnova S.A., Oganov R.G., Deev A.D., Imaeva A.E., Lukyanov М.М., Artamonova G.V., Gatagonova Т.М., et al, on behalf of the ESSE-RF study work team. Comorbidities of ischemic heart disease with other non-communicable diseases in adult population: age and risk factors association. Cardiovascular Therapy and Prevention, 2015; 14(4): 44–51 [In Russ.]

Kolesnikov SI, Savilov ED, Savchenkov MF, Leshchenko YaA, Malov IV, Anganova EV, Astaf'ev VA, Shugaeva SN. Sanitary-Epidemiological Status of Siberian Population (Medico-Demographical and Epidemiological Characteristics). Annals of the Russian Academy of Medical Sciences. 2016;71(6):472-481

Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey Methods. In WHO Monograph Series No. 56 2nd edition. Geneva: World Health Organization 1982; 149-172.

Chazova I.E., Ratova L.G., Boitsov S.A., Nebieridze D.V. Recommendations for the management of arterial hypertension Russian Medical Society of Arterial Hypertension and Society of Cardiology of the Russian Federation. System Hypertension 2010;3:5-26 / http://www.gipertonik.ru/files/journals/SG3(2010).pdf. Accessed on 13 May 2019.

Defining Adult Overweight and Obesity. https://www.cdc.gov/obesity/adult/defining.html. Accessed on 13 May 2019.

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011 Nov;32(22):2851-906.

Namekata T., Suzuki K., Ishizuka N., Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord 2011;10:11:51.

The method of volumetric sphygmography on the device Vasera VS-1500N: guidelines. V.A. Milyagin, I.V. Milyagina, M.A. Purygina, T.A. Osipenkova. Smolensk: SSMA 2014. [In Russ.]

The population of the Russian Federation for municipalities on January 1, 2017 - published on July 31, 2017. Federal Service of State Statistics. http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/publications/catalog/afc8ea004d56a39ab251f2bafc3a6fce. Accessed on 13 May 2019.

Gaisenok O.V., Dorokhov S.I., Kalashnikov S.V., Leonov A.S., Vlasova L.A. The value of population-based programs within “Healthy Heart Day” moves to identify hypertension and major risk factors for cardiovascular diseases. Profilakticheskaya meditsina 2017;20(3):17-21. [In Russ.]

Gaisenok OV, Medvedev PA, Trifonova SS, Shatalova IV, Martsevich SY, Sidorenko BA. Application of CAVI Index in Clinical Practice: Calculated Vascular Age as a Tool for Decision on Additional Examination of Patients With Cardiovascular Diseases. Kardiologiia 2015;55(7):51-6. [In Russ.]

Rogoza A.N., Kaveshnikov V.S., Trubacheva I.A., Serebriakova V.N., Zairova A.R., Zhernakova Y.V., Oshepkova E.V., Karpov R.S., Chazova I.E. Vascular Wall in Adult Population of Tomsk in the Framework Of The Project Essay RF. Systemic Hypertension 2014;11(4):42-48. [In Russ.]

Sumin A.N., Shcheglova A.V., Fedorova N.V., Artamonova G.V. Values of Cardial-Ankle Vascular Index in Healthy People of Different Age by the Data of Esse-RF Study in Kemerovskaya Region. Cardiovascular Therapy and Prevention. 2015;14(5):67-72. [In Russ.]

Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VI revision. The Russian Society of Cardiology. The Russian National Atherosclerosis Society. Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention. Journal of Atherosclerosis and Dyslipidaemias (JAD) 2017; 3: 5-22. [In Russ.] https://elibrary.ru/download/elibrary_29667695_24847695.pdf. Accessed on 13 May 2019.

Jousilahti P, Laatikainen T, Salomaa V, Pietilä A, Vartiainen E, Puska P. 40-Year CHD Mortality Trends and the Role of Risk Factors in Mortality Decline: The North Karelia Project Experience. Glob Heart. 2016 Jun;11(2):207-12. doi: 10.1016/j.gheart.2016.04.004.

Gaisenok O, Martsevich S, Tripkosh S, Lukina Y. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry. Rev Port Cardiol. 2015 Feb;34(2):111-6.

Oleg V. Gaisenok, Anton S. Leonov. Therapy in the Prevention of Thromboembolic Complications in Patients with Atrial Fibrillation: Prospects for Higher Appointment of New Oral Anticoagulants in Сlinical Рractice. Cardiology and Cardiovascular Research 2017; 1(2): 29-31

Wei MY, Ito MK, Cohen JD, Brinton EA, Jacobson TA. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education. J Clin Lipidol. 2013 Sep-Oct;7(5):472-83.

Sumin A.N., Bezdenezhnykh N.A., Fedorova N.V., Bezdenezhnykh A.V., Indukaeva E.V., Artamonova G.V. The Relationship of Visceral Obesity and Cardio-Ankle Vascular Index with Impaired Glucose Metabolism According to the Esse-RF Study in West Siberian Region. Klin Med (Mosk) 2018;96(2):137-146. [In Russ.]

National composition of Russia 27.07.2017 http://www.statdata.ru/nacionalnyj-sostav-rossii. Accessed on 13 May 2019.

Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation. 2016 Feb 23;133(8):742-55.

Yusuf S. Why do people not take life-saving medications? The case of statins. Lancet. 2016 Sep 3;388(10048):943-5.